Johnson & Johnson (JNJ) Approaches Actelion About a Takeover

November 25, 2016 6:36 AM EST

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Johnson & Johnson (NYSE: JNJ) has approached Actelion Ltd. (OTC: ALIOY) about a takeover, Bloomberg reported on Thursday. The story follows a StreetInsider report on Wednesday that the Switzerland-based pharmaceutical company attracted takeover interest from a major U.S.-based pharmaceutical company (JNJ was mentioned as a possible suitor).

Actelion has an enterprise value of over $17 billion, and if it agreed to be acquired before the end of the year it would be among the largest pharma deals of 2016.

The talks are said to be in the early states following Johnson & Johnson's initial offer and may not lead to a deal.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Rumors

Add Your Comment